SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rohit Nanavati who wrote (136)5/2/1997 8:49:00 AM
From: Bill Marble   of 998
 
Regarding Cowen Strong Buy rating:

I do not own CEPH any more, but I held it for most of last year (bought at $25, held on all the way to $14 and threw in the towel at $21).

I was a Cowen brokerage customer and received their reports weekly (I closed the account awhile ago, but I'm still on the list ;-) ). Cowen has had a stong buy rating on CEPH for at least a year and a half. When I bought it last year, their 12 mo target price was $60. Now, a year later, with the price still around $20, their 12 mo target is $45.

I wouldn't get too excited about the Cowen announcement - it's not really news and while they remain positive, they have radically adjusted their target.

I'm on the sidelines for this one, but I continue to follow the story (the option deal was interesting). I wish all of you the best of luck next week.

WEM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext